# US 2016/0235300 A1 · Analyte Meter Including an RFID Reader

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0235300 A1
- Document ID: US20160235300A1
- Status: Published application
- Kind: A1
- Application number: 15/136,310
- Filed: 2016-04-22
- Published: 2016-08-18
- Earliest claimed: 2005-02-08
- Assignees: Abbott Diabetes Care Inc.
- Applicants: Abbott Diabetes Care Inc.
- Inventors: Timothy T. Goodnow; Lei (Lawrence) He
- Web page: https://patentgrep.com/patent/US20160235300A1

## CPC

- A61B 5/0022: {Monitoring a patient using a global network, e.g. telephone networks, internet}
- A61B 5/0004: {characterised by the type of physiological signal transmitted}
- A61B 5/0026: {characterised by the transmission medium}
- A61B 5/14503: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors (A61B5/1459, A61B5/1464, A61B5/1473, A61B5/1482, A61B5/14865 take precedence)}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/1473: invasive, e.g. introduced into the body by a catheter
- A61B 5/14735: {comprising an immobilised reagent}
- A61B 5/1486: using enzyme electrodes, e.g. with immobilised oxidase
- A61B 5/1495: Calibrating or testing of in-vivo probes
- A61B 5/150358: {Strips for collecting blood, e.g. absorbent}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61B 5/7282: {Event detection, e.g. detecting unique waveforms indicative of a medical condition (cough events A61B5/0823; seizures A61B5/4094; sleep apnoea A61B5/4818)}
- A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)}
- A61B 90/90: Identification means for patients or instruments, e.g. tags
- A61B 90/98: using electromagnetic means, e.g. transponders
- G01N 33/48771: {Coding of information, e.g. calibration data, lot number}
- G06K 7/10366: {the interrogation device being adapted for miscellaneous applications}
- G08C 17/02: using a radio link
- A61B 2562/0295: Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
- A61B 2562/08: Sensors provided with means for identification, e.g. barcodes or memory chips
- A61B 2562/085: combined with means for recording calibration data
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G06K: GRAPHICAL DATA READING (image or video recognition or understanding G06V); PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G08C: TRANSMISSION SYSTEMS FOR MEASURED VALUES, CONTROL OR SIMILAR SIGNALS (fluid pressure transmitting systems F15B; mechanical means for transferring the output of a sensing member into a different variable G01D5/00; mechanical control systems G05G)

## Abstract

A glucose monitoring system, includes a glucose sensor strip or package of strips. The strip includes a substrate and a glucose monitoring circuit that has electrodes and a bodily fluid application portion of selected chemical composition. An antenna is integrated with the glucose sensor strip. A RFID sensor chip is coupled with the glucose sensor strip and the antenna. The chip has a memory containing digitally-encoded data representing calibration and/or expiration date information for the strip.

## Claims

### Claim at position 1

-58. (canceled)

### Claim 59

An analyte monitoring system for use in diabetes management, comprising:
a radio frequency identification (RFID) reader that transmits a first radio wave and receives a second radio wave; and
an analyte sensing device, comprising:
a partially or fully implantable in vivo analyte sensor; and
an RFID sensor comprising a memory in which digitally encoded diabetes information of the partially or fully implantable in vivo analyte sensor is stored therein,
wherein the RFID sensor receives the first radio wave from the RFID reader and, after receipt of the first radio wave, transmits the diabetes information in the second radio wave to the RFID reader, and
wherein the RFID reader reads the diabetes information in the second radio wave received from the RFID sensor.

### Claim 60 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID sensor is a passive RFID sensor.

### Claim 61 (depends on 60)

The analyte monitoring system of claim 60, wherein the first radio wave is an interrogation signal and the second radio wave is a backscattered radio wave, and wherein the RFID sensor transmits the second radio wave in response to impingement of the first radio wave on an antenna of the RFID sensor.

### Claim 62 (depends on 60)

The analyte monitoring system of claim 60, wherein the RFID sensor uses power from the first radio wave.

### Claim 63 (depends on 60)

The analyte monitoring system of claim 60, wherein the passive RFID sensor does not comprise a battery.

### Claim 64 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID sensor is an active RFID sensor.

### Claim 65 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID sensor is part of an RFID tag.

### Claim 66 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID sensor is a chip mounted on a PCB substrate.

### Claim 67 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID sensor comprises a transponder that receives the first radio wave and transmits the second radio wave, containing the diabetes information, after receipt of the first radio wave.

### Claim 68 (depends on 59)

The analyte monitoring system of claim 59, wherein the diabetes information is calibration information, expiration information, data representing a lot number, data representing a manufacture date, or data representing a sensor type.

### Claim 69 (depends on 59)

The analyte monitoring system of claim 59, wherein the analyte sensing device comprises an antenna.

### Claim 70 (depends on 69)

The analyte monitoring system of claim 69, wherein the antenna is a loop antenna.

### Claim 71 (depends on 69)

The analyte monitoring system of claim 69, wherein the antenna is a dipole antenna.

### Claim 72 (depends on 69)

The analyte monitoring system of claim 69, wherein the antenna is integrated with the in vivo analyte sensor.

### Claim 73 (depends on 72)

The analyte monitoring system of claim 72, wherein the in vivo analyte sensor comprises a substrate, and wherein the antenna comprises a conducting loop extending around substantially a perimeter of the substrate and has two ends coupled with the RFID sensor.

### Claim 74 (depends on 59)

The analyte monitoring system of claim 59, wherein the in vivo analyte sensor comprises a plurality of electrodes that include a working electrode and a counter electrode.

### Claim 75 (depends on 74)

The analyte monitoring system of claim 74, wherein the plurality of electrodes includes a reference electrode.

### Claim 76 (depends on 74)

The analyte monitoring system of claim 74, wherein the in vivo analyte sensor comprises an analyte monitoring circuit having the plurality of electrodes and a bodily fluid application portion.

### Claim 77 (depends on 59)

The analyte monitoring system of claim 59, wherein the analyte sensing device performs electrolysis on a bodily fluid.

### Claim 78 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID reader comprises a pump.

### Claim 79 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID reader comprises a housing with a display and one or more operational buttons.

### Claim 80 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID reader comprises a transceiver and an antenna.

### Claim 81 (depends on 80)

The analyte monitoring system of claim 80, wherein the RFID reader further comprises a directional coupler that couples the transceiver to the antenna.

### Claim 82 (depends on 80)

The analyte monitoring system of claim 80, wherein the transceiver and antenna of the RFID reader supply power to the RFID sensor with the first radio wave.

### Claim 83 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID reader has processing capability and reads the diabetes information from the second radio wave and uses the diabetes information to determine an analyte level of a bodily fluid.

### Claim 84 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID reader transmits a third radio wave to the RFID sensor, the third radio wave including information to be written to the RFID sensor.

### Claim 85 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID reader is capable of programming the RFID sensor.

### Claim 86 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID reader further comprises an analyte meter and a test strip port.

### Claim 87 (depends on 86)

The analyte monitoring system of claim 86, further comprising circuitry for determining the analyte level of a bodily fluid sample on a test strip inserted into the port.

### Claim 88 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID reader is integrated with an analyte meter.

### Claim 89 (depends on 59)

The analyte monitoring system of claim 59, further comprising a modular analyte meter.

### Claim 90 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID reader communicates data with an analyte meter by way of a cable, multi-pin connection, or wireless connection.

### Claim 91 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID reader shares processing capability with an analyte meter.

### Claim 92 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID reader shares memory with an analyte meter.

### Claim 93 (depends on 59)

The analyte monitoring system of claim 59, wherein the RFID reader is a component of another device.

### Claim 94 (depends on 59)

The analyte monitoring system of claim 59, wherein the analyte is glucose.

### Claim 95 (depends on 59)

The analyte monitoring system of claim 59, wherein the first radio wave is in a frequency band around 13.56 MHz.

### Claim 96 (depends on 59)

The analyte monitoring system of claim 59, wherein the first radio wave is in a frequency band around 2.45 GHz.
